Nissay Capital
Venture capitalTokyo · Pre-Seed–Late Stage · 1 people tracked
Also known as ニッセイ・キャピタル株式会社
Team · 1 people
from public directoriesWhat they invest in
from 7 of 7 portfolio companiesAI & Machine Learning ×4SaaS ×4Data & Infrastructure ×2Digital Health ×2Enterprise Software ×2Healthtech ×2AdTech ×1Cleantech ×1
HQs:Japan×6
Investments · 7 tracked
founders shown can be your intro pathRehab for JAPAN develops and provides "Rehab Cloud," a SaaS platform for elderly care and rehabilitation providers, along with "Rehab Studio," an online rehabilitation service, and conducts R&D on AI-based care technology.
AI & Machine LearningData & InfrastructureDigital HealthHealthtechLongevitySaaSTokyo, JP
大久保亮(代表取締役社長 CEO)
Exergy Power Systems develops and operates hybrid battery energy storage systems (BESS) and energy management systems for large-scale power consumers, factories, hospitals, and grid operators seeking to achieve net-zero targets.
CleantechClimate TechEnergyTokyo, JP
Dr Miura Daisuke(CEO)
ACROVE is a Japanese company focused on e-commerce, aiming to bring products to more consumers through EC (electronic commerce).
ConsumerData & InfrastructureE-commerceRetail TechSaaSTokyo, JP
Shunsuke Arai(代表取締役 社長執行役員 / グループCEO (Representative Director, President & Group CEO))Tetsuo Yamada(取締役 / 副社長執行役員 グループCOO)Toshiki Terashima(執行役員 CTO)Yuji Kozawa(執行役員 CAE)
Smart119 develops ICT-based technology aimed at solving problems in medical and emergency care settings to help treat more patients.
AI & Machine LearningDigital HealthEnterprise SoftwareHealthtechMedical DevicesKagoshima, JP
菊永 満(代表取締役社長)中田 孝明(代表取締役)
New Innovations develops OMO (Online-Merge-Offline) services and solutions, along with robots for industrial automation.
AI & Machine LearningDeep TechEnterprise SoftwareRoboticsSaaSTokyo, JP
Keito Nakao(Co-CEO & CTO)Tsutomu Yamada(Co-CEO)
Portfolio news
latest coverage across their companiesNew Innovations · itbusinesstoday.com · May 27, 2025
Frequently asked questions
- What stage does Nissay Capital invest at?
- Nissay Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth, Late Stage stages.
- What is Nissay Capital's typical check size?
- Nissay Capital typically writes checks of $610K – $71M.
- What sectors does Nissay Capital focus on?
- Nissay Capital focuses on Advanced Manufacturing, Biotech, Enterprise Software, Healthtech, Medical Devices, Retail Tech, SaaS, Sector Agnostic.
- Where is Nissay Capital located?
- Nissay Capital is headquartered in Tokyo, JP.
Similar investors
Khosla Ventures is a venture capital firm known for backing bold, contrarian bets in world-class teams that can reshape entire industries.
B Capital Group is a global venture capital firm that backs founders from early to late stage, with dedicated stage-based funds and a portfolio spanning technology, healthcare, and energy and resilience sectors.
IDG Capital is a multi-strategy investment platform founded in 1993 that supports entrepreneurs across the full business lifecycle, bridging East and West with a global presence and over 300 professionals.
SMBC Venture Capital operates as the corporate VC arm of Sumitomo Mitsui Banking Corporation with an unusually integrated "bank + VC + consultancy + talent" model that pairs a ¥15 billion fund with in-house sector specialists and post-investment executive dispatch capabilities. The fund is explicitly required to perform formal impact measurement and reporting alongside financial returns, targeting startups that address specific social issues like Japan's aging population and climate challenges as part of SMBC Group's ¥50 trillion sustainable finance target.